Over the last 25 years, Violetta has specialized in drug development at various biotechnology companies, where she was responsible for research and development programs and the preclinical and clinical development of new chemical entities. More recently, as Vice President of Drug Development at GLyPharma Therapeutics, she was in charge of the apraglutide development program that was awarded the “orphan drug” designation by the EMA and FDA and is currently in advanced clinical studies. She also has extensive expertise in setting up and monitoring collaborations with research institutes and pharmaceutical companies and has overseen large groups of scientists and technicians.

She holds a PhD in Neurosciences/Cytology from l’Université Pierre et Marie Curie (Paris, France) and completed a two-year fellowship at Tufts University (Boston, MA) in the Neuropharmacology Department. She began her professional career in academic education and basic research and held the position of Senior Lecturer in Pharmacy at René Descartes University (Paris, France). She has over 100 scientific publications and presentations.

• 

  Vice President of Preclinical and Clinical Operations in Find Therapeutics

  Designing Ground-Breaking Therapies Bringing Hope